SCHEMBL161677

SCHEMBL161677

CN(C)c1cc[n+](C#N)cc1.F[B-](F)(F)F

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.39
▸ TSHR P16473 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CHKA P35790 9/20 0.38
▸ MAPT P10636 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TP53 P04637 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4531332 1.00 ALDH1A1 (0.39) ALDH1A1TSHRALOX15HSD17B10CHKA
Acetonitrile SCHEMBL28221268 0.96 CHKA (0.36) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL1063959 0.92 ALDH1A1 (0.46) ALDH1A1TSHRALOX15HSD17B10CHKA
Hydrochloric Acid SCHEMBL29199774 0.90 ALDH1A1 (0.43) ALDH1A1TSHRALOX15HSD17B10CHKA
Bromide SCHEMBL384556 0.90 CHKA (0.47) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL1185630 0.86 CHKA (0.41) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL1193751 0.85 CHKA (0.32) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL7995708 0.85 CHKA (0.36) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL3630115 0.85 CHKA (0.36) ALDH1A1TSHRALOX15HSD17B10CHKA
SCHEMBL1185633 0.81 CHKA (0.36) ALDH1A1TSHRALOX15HSD17B10CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2347 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746917-A1 VACCINE GlaxoSmithKline Biologicals SA (BE) 2026-05-27 — — EP claimed
CN-122005771-A Composition of 31-valent pneumococcal capsular polysaccharide and application thereof 江苏坤力生物制药有限责任公司 2026-05-12 — — CN claimed
US-20260124287-A1 NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF PFIZER (US) 2026-05-07 — — US claimed
US-12465632-B2 Purified capsular polysaccharides of Streptococcus pneumoniae BIOLOGICAL E LIMITED (IN) 2025-11-11 — — US claimed
WO-2025224732-A1 MENINGOCOCCAL HEXAVALENT COMBINATION VACCINE TECHINVENTION LIFECARE PRIVATE LIMITED (IN) 2025-10-30 — — WO claimed
EP-3927685-B1 A PROCESS FOR THE SYNTHESIS ANTHRANILIC DIAMIDE COMPOUNDS AND INTERMEDIATES THEREOF PI INDUSTRIES LTD (IN) 2025-10-08 — — EP claimed
US-20250281601-A1 VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS PFIZER INC. (US) 2025-09-11 — — US claimed
US-12383611-B2 Neisseria meningitidis compositions and methods thereof PFIZER INC. (US) 2025-08-12 — — US claimed
US-20250228923-A1 COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-07-17 — — US claimed
CN-117919397-B Pneumococcal conjugate combined vaccine and preparation method thereof 北京智飞绿竹生物制药有限公司 2025-06-24 — — CN claimed
US-5849301-A Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) 1998-12-15 — — US claimed
WO-1998030239-A2 PROCESS FOR PREPARING CONJUGATE VACCINES INCLUDING FREE PROTEIN AND THE CONJUGATE VACCINES, IMMUNOGENS, AND IMMUNOGENIC REAGENTS PRODUCED BY THIS PROCEDURE LEES ANDREW (US) 1998-07-16 — — WO claimed
EP-0814833-A1 PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS Lees, Andrew (US) 1998-01-07 — — EP claimed
US-5693326-A COUPLING BACTERIAL POLYSACCHARIDE AND A PROTEIN TO FORM A IMMUNOSTIMULANT HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) 1997-12-02 — — US claimed
US-5651971-A Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE (US) 1997-07-29 — — US claimed
WO-1996029094-A1 PRODUCING IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED VIA ORGANIC CYANYLATING REAGENTS LEES ANDREW (US) 1996-09-26 — — WO claimed
WO-1996017941-A2 PRODUCTION OF C-TERMINAL AMIDATED PEPTIDES FROM RECOMBINANT PROTEIN CONSTRUCTS BIONEBRASKA, INC. (US) 1996-06-13 — — WO claimed
EP-0222380-B1 METHOD FOR STABILIZING CREATINE KINASE Roche Diagnostics GmbH (DE) 1993-03-17 — — EP claimed
US-4931392-A REACTING WITH DISULFIDE OR THIOSULFONATE AND CARBOHYDRATE BOEHRINGER MANNHEIM GMBH (DE) 1990-06-05 — — US claimed
EP-0222380-A2 Method for stabilizing creatine kinase Roche Diagnostics GmbH (DE) 1987-05-20 — — EP claimed
Send feedback